Kura Oncology, Inc. announced a private placement of 1,376,813 shares of its common stock at a price of $17.25 per share and pre paid warrants at a price of $17.2499 for the total gross proceeds of $150,000,000 on January 24, 2024. The pre paid warrant will be exercisable into common shares at a price of $0.0001. The private placement is expected to close on or about January 26, 2024, subject to customary closing conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.61 USD | -0.39% | -2.65% | +43.32% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.32% | 1.57B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.67% | 12.27B |
- Stock Market
- Equities
- KURA Stock
- News Kura Oncology, Inc.
- Kura Oncology, Inc. announced that it expects to receive $150 million in funding from EcoR1 Capital, LLC